IP Group PLC Life Sciences update event
08 Junho 2023 - 4:51AM
RNS Non-Regulatory
TIDMIPO
IP Group PLC
08 June 2023
FOR RELEASE ON 08 June 2023
IP Group - Life Sciences investor update
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the
Company"), which invests in breakthrough science and innovation
companies with the potential to create a better future for all,
announces that it will hold a life sciences investor update on
Thursday June 15 2023 featuring Dr Gordon Sanghera, CEO of Oxford
Nanopore Technologies plc, and Professor Sir Peter Donnelly, CEO of
portfolio company Genomics .
The event will be hosted by CEO Greg Smith and Dr Sam Williams,
Managing Partner of Life Sciences at IP Group, and, as announced on
20 April 2023, will be followed by the Group's Annual General
Meeting at 11am. Further details of the event and how to register
can be found here: bit.ly/3oUjNqb .
The update will also be available remotely through the Investor
Meet Company platform. Questions can be submitted in advance of the
event via the Investor Meet Company Platform up to 9am the day
before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free via:
https://www.investormeetcompany.com/ip-group-plc/register-investor
. Investors who already follow IP Group plc on the Investor Meet
Company platform will automatically be invited.
No material new information will be released by the Company
during the presentation.
For more information, please contact:
IP Group plc www.ipgroupplc.com
+44 (0) 20 7444 0062/+44 (0)
Liz Vaughan-Adams, Communications 7967 312125
Portland
Vic Wallin +44 (0) 7973 823119
Alex Donaldson +44 (0) 7516 729702
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future.
As the most active UK based, early stage science investor , we
develop and support some of th e world's most exciting businesses
in deeptech, life sciences and cleantech (led by Kiko Ventures).
Through Parkwalk, the UK's largest growth EIS fund manager, we also
back world-changing innovation emerging in leading universities and
research institutions. Our specialist investment team combines
sector expertise with an international approach. Together we have a
strong track record of success, having backed high-profile
companies including Oxford Nanopore Technologies plc, First Light
Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of
the London Stock Exchange under the code IPO.
For more information, please visit our website at
www.ipgroupplc.com .
ENDS
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRAUPUBCQUPWUMR
(END) Dow Jones Newswires
June 08, 2023 03:51 ET (07:51 GMT)
Ip (LSE:IPO)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Ip (LSE:IPO)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024